Your cell phone doesn’t give you cancer, 18-year Danish study shows

You’re as likely to get cancer from using your cell phone as from drinking coffee. Say what? That’s right, cell phone radiation is not dangerous.

The results of a an 18-year study by researchers in Denmark, tracked the incidence of certain cancers among cell phone users, and found that cell phone owners, and those who did not own cell phones were equally likely to get cancer.

The study, which was led by the Danish Center … Continue Reading

World Health Organization: cell phones possibly carcinogenic (updated)

Cell phone radiation might be carcinogenic — meaning the radiation could be linked to some cases of cancer — according to a panel assembled by the World Health Organization (WHO) to study the effects of the devices.

The WHO’s International Agency for Research on Cancer (IARC) previously held that cell phone radiation was not carcinogenic. That partly silenced many critics who claimed cell phone radiation was causing brain tumors and that cell phones were more … Continue Reading

Facebook's Causes reels in $9M and defends online activism

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life-science briefing: Thursday, April 3, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life-science briefing: Friday, March 14, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life-science briefing: Tuesday, March 11, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Precision Thera merger with "blank check" firm Oracle Healthcare collapses

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Wednesday, March 5, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Thursday, Feb. 28, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Wednesday, Feb. 27, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Monday, Feb. 4, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Friday, Jan. 25, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Thursday, Jan. 24, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Monday, Jan. 14, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Alder Bio and its yeast-produced antibodies take in $40M

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Thursday, Jan. 3, 2008

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Precision Thera drops IPO, goes public via reverse merger

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Cancer-drug biotech Agensys sells to Astellas for $387M — but is it a pig in a poke?

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Monday, Nov. 12, 2007

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading

Life sciences briefing: Friday, Nov. 9, 2007

A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.

The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking sites as a way to raise money for fighting everything from cancer to genocide. The notion of online activism has recently faced criticism from New Yorker writer Malcolm Gladwell, prompting a passionate response from a … Continue Reading